Inarigivir
- Generic Name
- Inarigivir
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H26N7O10PS
- CAS Number
- 475650-36-3
- Unique Ingredient Identifier
- TQ0A9FIV71
- Background
Inarigivir is under investigation in clinical trial NCT03434353 (Study to Evaluate the Antiviral Activity of Inarigivir (GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB)).
- Associated Conditions
- -
- Associated Therapies
- -
A Fixed-Sequence, Drug-Drug Interaction Study Between Multiple Oral Doses of Inarigivir Soproxil and a Single Oral Dose of Midazolam in Healthy Subjects
- First Posted Date
- 2018-04-10
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- F-star Therapeutics, Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT03493698
- Locations
- 🇳🇱
University Medical Center Groningen, Groningen, Netherlands
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath